An interventional study of Ramosetron and Normal saline in Hysteroscopy, sponsored by Seoul National University Bundang Hospital. Status unknown at 1 site in Korea, Republic of. Open to female participants aged 20 Years to 60 Years. Per ClinicalTrials.gov, last updated 2018-04-20.
Sponsored by Seoul National University Bundang Hospital · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Nausea and vomiting after general anesthesia is one of the common anesthetic complications. If the patient is discharged from the hospital after surgery, proper treatment may be delayed or impossible if nausea or vomiting occurs. Thus, It is necessary to prevent these symptoms beforehand. Patients who underwent gynecologic surgery will be treated with prophylactic ramosetron to determine whether the frequency of nausea and vomiting is decreased when the patient returned home after discharge.
Seoul National University Bundang Hospital is the lead sponsor of 377 studies on the registry; 56 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Drug: Ramosetron
Drug: Normal saline
Ramosetron 0.3 mg is administered after induction of general anesthesia.
Normal saline 2 ml is administered after induction of general anesthesia.
The change in the occurrence of postoperative nausea
Time frame: Postoperative 30 minute, 3 hour, 24 hour, and 48 hour
The change in the occurrence of postoperative vomiting
Time frame: Postoperative 30 minute, 3 hour, 24 hour, and 48 hour
The change of postoperative pain score
Score range is from 0 to 10.
Time frame: Postoperative 30 minute, 3 hour, 24 hour, and 48 hour
The change in the number of postoperative administration of rescue analgesic drug
Time frame: Postoperative 30 minute and 3 hour
The change in the number of postoperative administration of rescue antiemetic drug
Time frame: Postoperative 30 minute and 3 hour
The change of patient's satisfaction score
Score range is from 0 to 10.
Time frame: Postoperative 30 minute, 3 hour, 24 hour, and 48 hour
Started Mar 2018 (actual). Primary completion is estimated for Feb 2019, 11 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Ramosetron
Seoul National University Bundang Hospital →